News

Prestigious DIAMOND Awards Celebrate Preston Dermatology's Excellence

Prestigious DIAMOND Awards Celebrate Preston Dermatology's Excellence

Prestigious DIAMOND Awards Recognize Outstanding Dermatology Practices

The world of dermatology is constantly evolving, and at the forefront of this evolution is Preston Dermatology & Skin Surgery Center. This esteemed practice has recently been awarded the prestigious Gold for Best Dermatologist by 5 West Magazine and Bronze for Best Dermatologist by Midtown Magazine. These accolades are a testament to their excellence in dermatologic care.

Recognition for Excellence in Dermatology

Located in North Carolina, Preston Dermatology stands out in a field that requires both skill and sensitivity. Led by board-certified dermatologist Dr. Sheel Desai Solomon, the practice has gained the trust of its patients through a commitment to providing superior care. Dr. Solomon expressed her gratitude, stating, "We are deeply grateful for the support of our patients throughout the area and the readers of these magazines." This recognition represents the hard work and dedication of the entire team.

A Commitment to Patient-Centered Care

The DIAMOND Awards highlight businesses that have demonstrated remarkable service to their communities. Being voted by readers of influential magazines like 5 West and Midtown underscores Preston Dermatology's dedication to patient care. Dr. Solomon emphasizes that their team is committed to delivering personalized healthcare through the most advanced treatments available, ensuring that every patient receives results-driven care.

A Comprehensive Range of Dermatology Services

Preston Dermatology & Skin Surgery Center offers an extensive range of services tailored to meet each patient's needs. Their offerings include medical dermatology, skin cancer surgery, cosmetic treatments, laser therapies, and in-office radiation oncology. With the practice's convenient locations in Cary, Wake Forest, and Holly Springs, patients have access to same-day appointments, making it easier for them to schedule necessary care.

About Preston Dermatology & Skin Surgery Center

Founded in 2017, Preston Dermatology & Skin Surgery Center has rapidly evolved into a leading dermatology practice in North Carolina. Dr. Sheel Desai Solomon's vision of delivering patient-centered care is supported by a dedicated team that prioritizes clinical excellence. The practice specializes in a wide array of dermatological services, ensuring comprehensive skin care that addresses both medical and cosmetic concerns.

Contact Information

Patients and prospective clients looking for more information or wishing to schedule an appointment can easily reach out to Preston Dermatology. The practice can be contacted at (919) 388-9103, providing a direct line to their services. Patients can also visit their website for detailed insights into their offerings.

Frequently Asked Questions

What awards did Preston Dermatology & Skin Surgery Center receive?

Preston Dermatology received Gold for Best Dermatologist from 5 West Magazine and Bronze for Best Dermatologist from Midtown Magazine.

Who leads Preston Dermatology?

The practice is led by Dr. Sheel Desai Solomon, a board-certified dermatologist known for her patient-centered approach.

What services are offered at Preston Dermatology?

The center offers medical dermatology, skin cancer surgery, cosmetic treatments, laser therapies, and in-office radiation oncology.

When was Preston Dermatology established?

Preston Dermatology & Skin Surgery Center was founded in 2017 by Dr. Solomon.

How can I schedule an appointment?

To schedule an appointment, you can call (919) 388-9103 or visit their website for more information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 89

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 27

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Pathalys' Phase 3 Data Shows Promise for CKD Drug

Updated Category News Views 63

A Glimpse at Pathalys Pharma's Recent Win This is some groundbreaking stuff emerging from Pathalys Pharma. Their investigational drug, upacicalcet, has just clinched a significant victory in two crucial Phase 3 trials - PATH-1 and PATH-2 - aimed at treating Secondary Hyperparathyroidism (SHPT) in patients with end-stage kidney disease undergoing hemodialysis. With SHPT...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 85

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 98

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 66

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 192

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 46

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
John Wong's Decade as Estate Planning Specialist

Updated Category News Views 68

One man's legacy isn’t built overnight, especially not in estate planning. And John L. Wong's decade of being a certified specialist by the State Bar of California tells a story of perseverance and grit. Now, at the helm of Modern Wealth Law in Irvine, California, Wong is a name that echoes through the halls of estate planning law with authority and respect. Creating...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Medical Diagnostics with Advanced AI Defense

Updated Category News Views 163

Innovative Defense System for Medical Digital Twins This method enables medical digital twins to achieve 98% accuracy in breast cancer prediction, even under adversarial attacks. Medical digital twins are sophisticated virtual models that mirror real biological systems, offering healthcare professionals a powerful tool for predicting and diagnosing diseases. However,...

Continue Reading
Honeywell's Big Play: Amended Deal to Acquire Catalyst Tech

Updated Category News Views 186

What's the Deal with Honeywell? Honeywell (NASDAQ: HON) just mixed things up a bit—like, they changed the game plan on their agreement to acquire Johnson Matthey's Catalyst Technologies. The original asking price took a haircut, getting whittled down from £1.8 billion to £1.325 billion. I mean, who wouldn't appreciate a discount nowadays? Right? The long stop date is...

Continue Reading
Transformation of Senior Living Market Driven by AI Trends

Updated Category News Views 404

Transforming the Senior Living Market: The Role of AI The senior living sector is poised for substantial evolution, with market expansion projected at USD 130.9 billion between 2025 and 2029. The driving force behind this growth is the aging baby boomer population that is reshaping the landscape of senior living options. The market is growing at a compound annual growth...

Continue Reading
Saudi Arabia Eyes the Future with AAM Feasibility Study

Updated Category News Views 11

Bracing for Saudi Arabia's Air Mobility Leap Here's something you don't see every day: Boeing Saudi Arabia and the Kingdom's top aviation folks are calling in the big guns—partnering with SkyGrid and KAUST—for a serious dive into the how-tos of Advanced Air Mobility (AAM) across Saudi airspace. This isn't just about slapping some high-tech drone stickers on existing...

Continue Reading
Investment Boost: Live Oak Ventures Supports AI Innovations

Updated Category News Views 263

Live Oak Ventures Announces a Strategic Investment Recently, Live Oak Ventures, the investment arm of Live Oak Bancshares, Inc., made headlines by investing in Cascading AI, Inc. (Casca), a leading platform that revolutionizes loan applications and originations through responsible artificial intelligence. Collaboration Aimed at Streamlining Loan Processes Live Oak Bank is...

Continue Reading